| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/19/2011 | DE202010009243U1 Zubereitung Preparation |
| 09/19/2011 | CA2696811A1 Glucosamin pro-drugs |
| 09/16/2011 | CA2708068A1 Hydrolyzed type i collagen composition and use for treatment of ocular tissue |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113060A2 Antiviral compounds and methods of use thereof |
| 09/15/2011 | WO2011113047A2 Compositions and methods for characterizing breast cancer |
| 09/15/2011 | WO2011113041A2 Neutralization of flt3 ligand as a leukemia therapy |
| 09/15/2011 | WO2011113036A2 Compositions and methods for expanding bfu-e cells |
| 09/15/2011 | WO2011113030A2 Human cancer micro-rna expression profiles predictive of chemo-response |
| 09/15/2011 | WO2011113024A1 Compositions and methods for healing of skin wounds |
| 09/15/2011 | WO2011113018A1 Measurement and control of biological time |
| 09/15/2011 | WO2011113013A2 Methods and compositions for treating viral or virally-induced conditions |
| 09/15/2011 | WO2011113005A2 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo) |
| 09/15/2011 | WO2011112997A1 Novel compositions and methods |
| 09/15/2011 | WO2011112995A1 Imidazopyridines syk inhibitors |
| 09/15/2011 | WO2011112988A1 Ophthalmic formulations |
| 09/15/2011 | WO2011112969A1 Poly(ethylene glycol) derivatives for metal-free click chemistry |
| 09/15/2011 | WO2011112956A1 Agonist/antagonist compositions and methods of use |
| 09/15/2011 | WO2011112933A1 Methods for the treatment of non-hodgkin's lymphomas using lenalidomide, and gene and protein biomarkers as a predictor |
| 09/15/2011 | WO2011112913A1 Maternal sialic acid supplementation |
| 09/15/2011 | WO2011112900A2 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 09/15/2011 | WO2011112896A1 Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 09/15/2011 | WO2011112893A2 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 09/15/2011 | WO2011112892A1 High-purity steviol glycosides |
| 09/15/2011 | WO2011112889A2 β-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY |
| 09/15/2011 | WO2011112875A2 Foamable formulation |
| 09/15/2011 | WO2011112867A1 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas |
| 09/15/2011 | WO2011112864A1 Parenteral formulations of macrolide antibiotics |
| 09/15/2011 | WO2011112859A2 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | WO2011112858A1 Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase |
| 09/15/2011 | WO2011112840A2 Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof |
| 09/15/2011 | WO2011112828A1 Pde10 inhibitors and related compositions and methods |
| 09/15/2011 | WO2011112769A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112761A1 Crystalline salts of a potent hcv inhibitor |
| 09/15/2011 | WO2011112733A1 Carbohydrate-polyamino acid-drug conjugates |
| 09/15/2011 | WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112717A1 A novel mucosal vaccination approach for herpes simplex virus type-2 |
| 09/15/2011 | WO2011112695A1 Compositions for masking the flavor of nutrients and methods for making same |
| 09/15/2011 | WO2011112689A2 Saltz of an indazolylpyrrolotriazine |
| 09/15/2011 | WO2011112687A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112685A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | WO2011112679A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | WO2011112678A1 Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy |
| 09/15/2011 | WO2011112666A1 Combination anti-cancer therapy |
| 09/15/2011 | WO2011112662A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | WO2011112657A1 Fatty acid conjugates of quetiapine, process for making and using the same |
| 09/15/2011 | WO2011112635A1 Cdc7 kinase inhibitors and uses thereof |
| 09/15/2011 | WO2011112623A1 Thioxanthone-based autophagy inhibitor therapies to treat cancer |
| 09/15/2011 | WO2011112609A1 Combination therapy for treating breast cancer |
| 09/15/2011 | WO2011112602A1 Analgesic compounds, compositions, and uses thereof |
| 09/15/2011 | WO2011112588A2 Compositions and methods for treating inflammatory disorders |
| 09/15/2011 | WO2011112535A2 Propionic acids, propionic acid esters, and related compounds |
| 09/15/2011 | WO2011112516A1 Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides |
| 09/15/2011 | WO2011112499A1 Compositions, methods, and devices for the treatment of dysmenorrhea |
| 09/15/2011 | WO2011112434A1 Compositions and methods for producing consumables for patients with dysphagia |
| 09/15/2011 | WO2011112429A1 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 09/15/2011 | WO2011112428A2 Arylvinylazacycloalkane compounds for constipation |
| 09/15/2011 | WO2011112414A2 Compound, composition, and method for protecting skin from high energy visible light |
| 09/15/2011 | WO2011112358A1 Lenalidomide and thalidomide immunoassays |
| 09/15/2011 | WO2011112264A1 Compounds as rorϒt modulators and uses thereof |
| 09/15/2011 | WO2011112263A1 AMIDO COMPOUNDS AS RORγt MODULATORS AND USES THEREOF |
| 09/15/2011 | WO2011112243A2 Beta -adrenergic receptor agonists and uses thereof |
| 09/15/2011 | WO2011112191A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011112186A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011112167A1 Compositions and methods for diabetes treatment |
| 09/15/2011 | WO2011112166A1 Method of treatment |
| 09/15/2011 | WO2011112161A1 Extended release thiocolchicoside tablets |
| 09/15/2011 | WO2011112160A1 Extended release trimetazidine tablets |
| 09/15/2011 | WO2011112156A1 Anti-cancer agent delivery vehicles capable of improved laoding |
| 09/15/2011 | WO2011112116A1 Bath drug and method for using said drug in the treatment and prophylaxis of discirculatory encephalopathy |
| 09/15/2011 | WO2011112082A1 Sterile alginate-based aqueous composition for medical use and process for the preparation thereof |
| 09/15/2011 | WO2011112071A2 Synergistic effect of tocotrienols and curcumin |
| 09/15/2011 | WO2011112067A1 A herbal composition having anti-obesity property |
| 09/15/2011 | WO2011111971A2 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 09/15/2011 | WO2011111880A1 Pharmaceutical composition for treating or preventing diseases caused by the nuclear export of gsk3, including a compound for inhibiting the nuclear export of gsk3 |
| 09/15/2011 | WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
| 09/15/2011 | WO2011111824A1 Method for proliferating cardiomyocytes using micro-rna |
| 09/15/2011 | WO2011111818A1 Sustained release type pharmaceutical composition containing mosapride or salt thereof |
| 09/15/2011 | WO2011111817A1 Benzazepine compound |
| 09/15/2011 | WO2011111809A1 Ketoprofen-containing aqueous adhesive skin patch |
| 09/15/2011 | WO2011111804A1 Antiprotozoal compound originating in coelenterata |
| 09/15/2011 | WO2011111738A1 Novel fki-4429 substance and method for producing same |
| 09/15/2011 | WO2011111715A1 Nucleic acid capable of regulating cell cycle |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111707A1 Allergy inhibitor |
| 09/15/2011 | WO2011111675A1 Novel indole derivative |
| 09/15/2011 | WO2011111384A1 Transdermal composition containing therapeutic agent for parkinson's disease |
| 09/15/2011 | WO2011111355A1 Prophylactic/therapeutic agent for peripheral neuropathy comprising l-serine |
| 09/15/2011 | WO2011111143A1 Medicament for rheumatoid arthritis |
| 09/15/2011 | WO2011111070A2 Novel injectable combination |
| 09/15/2011 | WO2011111066A2 Composition and uses thereof |
| 09/15/2011 | WO2011111026A1 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation |
| 09/15/2011 | WO2011110954A1 Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
| 09/15/2011 | WO2011110939A2 Pharmaceutical compositions of substituted benzhydrylpiperazines |
| 09/15/2011 | WO2011110876A1 Novel salts for the manufacture of pharmaceutical compositions |
| 09/15/2011 | WO2011110866A1 Phytocannabinoids in the treatment of cancer |
| 09/15/2011 | WO2011110859A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 09/15/2011 | WO2011110858A1 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |